Non-Compliant Balloon Catheter Non-Compliant Pressure Technology: Delivers accurate dilatation with minimal balloon growth, to reduce additional vessel injury during post-dilatation in unyielding fibrocalcified-type lesions. Controlled minimal balloon growth (5%) between NP & RBP for flat compliance High pressure catheter (RBP up to 20 atm) “One-Body” Tapered Tip Design: Seamless transition of tip-to-balloon for enhanced crossability…
Chronic Total Occlusion Dilatation Catheter The 3-in-1 balloon: CTO (1.00mm), high pressure (up to 24 bar RBP) & OTW (used instead of a microcatheter) “One-Body” Tapered Tip Design for enhanced crossability Ultra Pressure Technology: New semi-compliant balloons featuring higher burst pressures in a semi-compliant balloon design, provide resistance against potential pin hole rupture during pre-dilatation.…
ALERT ON RECRUITMENT FRAUD There have been instances of fraudulent job postings and offers, claiming to derive from Rontis companies of the Rontis group (Rontis). These fraudulent offers are asking for personal and financial information from applicants and sometimes require applicants to proceed in payments for their participation in the recruitment process. We kindly…
Semi-Compliant Coronary Balloon Catheter “A smooth and effective choice for all lesions” Ultra Pressure Technology A new semi-compliant Rx balloon featuring higher RBPs; allows greater flexibility of use in real world cases* “One-Body” Tip Design Enhanced trackability and crossability Ultraslim Bond Technology Slim & seamless distal catheter tip transitions minimize tip profiles & enhance balloon…
Rontis enters into exclusive distribution agreement with Nipro USA Nipro USA launches first Rontis PTA Balloon Catheter Rontis Corporation S.A. announces that its Swiss subsidiary Rontis AG (Zug, Switzerland) has signed an agreement with Nipro Medical Corporation (Miami, USA), a wholly-owned subsidiary of Nipro Corporation, for the exclusive distribution of the Rontis Cronus™ HP…
Rontis participated as an exhibitor in CPHI Worldwide 2015 Rontis Corporation continued its successful presence in the global pharmaceutical exhibition CPHI, in Madrid, participating as an exhibitor for the third consecutive year. This year the 3-day exhibition which was hosted by the congress center “IFEMA, Feria de Madrid”, on the 13th-15th of October 2015, attracted…
The EuroPCR 2014 is going to be held in Paris, France, between the 20th and the 23rd of May. Rontis is going to participate with a booth, as for many years now, so that we conduct our meetings with KOLs and partners and get to meet new ones. Meet us at our booth P02, Hall Paris, Level 1.
Below-The-Knee Balloon Catheter – Rx – 0.014″ “The effective 0.014″ to lower leg ischemia” Designed to feature the unique aspects surrounding the anatomy and physiology of below-the-knee vessels such as smaller vessel diameter and the more sluggish flow pattern. Short, flexible and tapered tip 0.016’’ (lowest in class) engineered to promote easier navigation since occlusions are more…
Balloon Catheter – Rx – 0.018″ “The only 0.018″ solution now 4-6F for cross over” Versatile balloon catheter engineered to meet the challenges of renal and infra-inguinal procedures through smaller diameter introducer sheath combining reliable deliverability and trackability. Facilitates advancement through complex lesions taking advantage of the monorail catheter design Rx design with reinforced PTFE coated hypotube…
Non-Vascular Balloon Catheter – OTW – 0.035″ “Non-Vascular cases provided with the optimal solution” The product designed to manage benign and malignant obstructions of the bile duct or other anatomical non-vascular tubular structures. OTW design concept provides added control Rontis’ proprietary hydrophilic coating, HiFlow for excellent lubricity Tri-folding/Hexa-folding balloon technology for optimal profile maintenance 2 Gold…